CO5611117A2 - COMBINATION OF ORGANIC COMPOUNDS - Google Patents

COMBINATION OF ORGANIC COMPOUNDS

Info

Publication number
CO5611117A2
CO5611117A2 CO04098754A CO04098754A CO5611117A2 CO 5611117 A2 CO5611117 A2 CO 5611117A2 CO 04098754 A CO04098754 A CO 04098754A CO 04098754 A CO04098754 A CO 04098754A CO 5611117 A2 CO5611117 A2 CO 5611117A2
Authority
CO
Colombia
Prior art keywords
combination
pharmaceutically acceptable
acceptable salt
organic compounds
group
Prior art date
Application number
CO04098754A
Other languages
Spanish (es)
Inventor
Robert Edson Damon
Thomas Edward Hughes
Bryan Burkey
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5611117A2 publication Critical patent/CO5611117A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1.- Una combinación de cuando menos dos componentes seleccionados a partir del grupo que consiste en:(i) un inhibidor de HMG-CoA-reductasa o una sal farmacéuticamente aceptable del mismo, seleccionado a partir del grupo que consiste en atorvastatina, cerivastatina, fluvastatina, lovastatina, pitavastatina, pravastatina, rosuvastatina, y simvastatina, y (ii) a) un potenciador de la secreción de insulina o una sal farmacéuticamente aceptable del mismo, ó b) un sensibilizante a la insulina o una sal farmacéuticamente aceptable del mismo.1. A combination of at least two components selected from the group consisting of: (i) an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, selected from the group consisting of atorvastatin, cerivastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin, and (ii) a) an insulin secretion enhancer or a pharmaceutically acceptable salt thereof, or b) an insulin sensitizer or a pharmaceutically acceptable salt thereof.

CO04098754A 2002-03-22 2004-10-04 COMBINATION OF ORGANIC COMPOUNDS CO5611117A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66752002P 2002-03-22 2002-03-22

Publications (1)

Publication Number Publication Date
CO5611117A2 true CO5611117A2 (en) 2006-02-28

Family

ID=42169369

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04098754A CO5611117A2 (en) 2002-03-22 2004-10-04 COMBINATION OF ORGANIC COMPOUNDS

Country Status (1)

Country Link
CO (1) CO5611117A2 (en)

Similar Documents

Publication Publication Date Title
WO2000048626A3 (en) Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease
BG105559A (en) STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR
MX2009003920A (en) Statin and omega-3 fatty acids for reduction of apo-b levels.
DE60001371D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN HMG-COA REDUCTASE INHIBITOR
IE970731A1 (en) Product and method for the treatment of hyperlipidemia
EP1314425A4 (en) Medicinal compositions for preventing or treating heart failure
BRPI0413468A (en) pyrrol-based hmg-coa reductase inhibitors
DK1200385T3 (en) Crystals of sodium salt of pravastatin
MY118381A (en) Statin-carboxyalkylether combinations
ATE444299T1 (en) NEW BORONATE ESTERS
AR048668A1 (en) HYPOOCOLESTEROLEMIANT COMPOSITIONS AND PROCEDURE TO PREPARE THEM
BRPI0417138A (en) n-alkyl pyrroles as hmg coa reductase inhibitors
CO5611117A2 (en) COMBINATION OF ORGANIC COMPOUNDS
JP2008063322A5 (en)
RU2007148908A (en) COMPOSITIONS FOR REDUCING THE RISK OF ARCTHYME CAUSED BY MEDICINES
BG106918A (en) Perocess for the preparation of sodium salts of statins
CA2529367A1 (en) Preventing atrial fibrillation (af) with the use of statin drugs
WO2011031964A3 (en) Inhibitors of biofilm formation
BR9813539A (en) Combinations of lp (a) inhibitor and antihyperlipidemic statin
JP2003524582A5 (en)
JP2006176498A5 (en)
JP2004115500A5 (en)
PL367885A1 (en) Methyl analogs of simvastatin as novel hmg-coa reductase inhibitors
TH78302B (en) Combination of organic compounds
TH78302A (en) Combination of organic compounds

Legal Events

Date Code Title Description
FC Application refused